Aspire Biopharma Holdings, Inc. Derivative Liability, Current
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-08-13
- 2025-12-31: Derivative Liability, Current $40.95K.
- 2025-09-30: Derivative Liability, Current $3.55M.
| Period end | Derivative Liability, Current |
|---|---|
| 2025-12-31 | $40.95K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.55M 10-Q · filed 2025-11-14 |